The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Axonics today announced its R20 rechargeable sacral neuromodulation (SNM) system has received CE Mark approval for use in adults with overactive bladder and/or fecal incontinence. The implant can last ...

Fowler’s syndrome is a rare condition of the urinary tract characterised by the inability of the urinary sphincter to relax, ...

The battery-free percutaneous sacral neuromodulation system has comparable efficacy to published rates for traditional sacral neuromodulation devices. The US Food and Drug Administration (FDA) has ...

94% of Test-Phase Responders Achieved Significant Symptom Relief with Zero Serious Device-Related Adverse Events New Data Suggests 30 Minutes of Daily iSNM Therapy Provides UUI Symptom Relief ...

IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc., the developer of the first rechargeable Sacral Neuromodulation (r-SNM™) System for the treatment of urinary and fecal ...

Add Yahoo as a preferred source to see more of our stories on Google. Neuromodulation systems are becoming increasingly popular for the treatment of UUI. Credit: designerNFMR / Shutterstock.com.

Limin Liao et al, Sacral Neuromodulation Using a Novel Device with a Six–contact-point Electrode for the Treatment of Patients with Refractory Overactive Bladder: A Multicenter, Randomized, ...

Neuspera Medical today highlighted that the Centers for Medicare & Medicaid Services (CMS) has confirmed the assignment of the billing code for the Neuspera Sacral Neuromodulation System (SNM) to ...

Reimbursement Parity Advances Patient Access and Will Help More Patients Avoid the Pain, Complications, and Repeat Surgeries Common in the $1 Billion Legacy Sacral Neuromodulation (SNM) Market Served ...